Oral contraceptive pills are birth control pills including progestin and estrogen hormones. These hormones induce contraception/birth control by preventing ovulation. These pills are also known as combined pills or combined oral contraceptive pills (COCP).
By type of product, the oral contraceptive pills market has been segmented into progestin-only, combination, and others. The combination oral contraceptive pills segment led the overall market in 2014 and is projected to register the highest growth rate over the course of the forecast period. This growth can be attributed to their higher efficiency in preventing pregnancies, their easy availability, and their rising preference among consumers.

The global Oral Contraceptive Pills market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oral Contraceptive Pills volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Contraceptive Pills market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oral Contraceptive Pills in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oral Contraceptive Pills manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer
Janssen Global Services
Allergan,plc (Actavis)
Teva Pharmaceutical
Piramal Enterprises
Pfizer
Merck
Mankind Pharma

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Generic
Branded

Segment by Application
Retail Pharmacy
Online Pharmacy